?? EPA Launches Series of Deregulatory Actions Targeting Chemicals Rules The Trump administration’s EPA just announced a string of actions to pause, weaken, or reverse chemicals-related rules, signaling a major shift in regulatory strategy. ?? Key developments covered in AgencyIQ’s new analysis: ?? TSCA risk management rules delayed or reconsidered ?? Repeal of recent procedural and policy updates ?? Impact on PFAS, workplace protections, and chemical safety standards With more changes likely ahead, companies must understand how these moves could reshape compliance obligations across the chemicals sector. ?? Read AgencyIQ’s full breakdown of what’s happening and what to expect next ?? Link in the comments below! #RegulatoryAffairs #ChemicalsRegulation #TSCA #EPA #PFAS #ProductStewardship #Compliance #AgencyIQ
关于我们
AgencyIQ is a regulatory intelligence solution that simplifies complex regulation, facilitates next steps, and improves outcomes by processing, analyzing, and helping subscribers search, track, analyze, and communicate important regulatory information. We offer an unrivaled trifecta of deep research and regulatory expertise, well-sourced reporting capabilities of one of the world’s premiere non-partisan newsrooms powered by an information and intelligence technology platform to enhance the capabilities of your teams.
- 网站
-
https://www.agencyIQ.com
AgencyIQ的外部链接
- 所属行业
- 信息服务
- 规模
- 11-50 人
- 总部
- Arlington，Virginia
- 类型
- 私人持股
- 创立
- 2020
- 领域
- Regulatory Affairs、Regulatory Intelligence和Regulatory Strategy
地点
-
主要
获取路线
1000 Wilson Blvd
US，Virginia，Arlington，22209
AgencyIQ员工
动态
-
AgencyIQ转发了
It has been two months since the start of the Trump administration, and deregulatory and downsizing efforts are starting to have effects on the FDA and the life sciences industry it regulates. Where do things go from here? Join AgencyIQ's Alexander Gaffney, MS, RAC and Laura DiAngelo on March 25th for an informative and actionable webinar focused on how the new Trump administration continues to affect health care product regulation. We will provide in-depth explanations of how FDA policies have been impacted so far, what we’re expecting to happen next, analysis of important staffing changes, emerging trends and policies, and a preview of what we expect from the FDA’s new commissioner, Marty Makary. AgencyIQ’s experts will also be on-hand to answer your questions live. https://lnkd.in/dxysm484
-
?? We’re #Hiring: Join AgencyIQ’s Regulatory Intelligence Team! ?? Are you a regulatory expert passionate about helping industry leaders navigate complex policy landscapes? AgencyIQ—POLITICO’s regulatory intelligence division—is expanding and looking for three exceptional professionals to join our team. ?? Open Positions: ?? ?? Research Director – Food & Chemicals Regulation https://lnkd.in/eajdcgxp ?? ?? Research Operations Manager – Food Regulation https://lnkd.in/e8mcj_er ?? ?? Senior Research Analyst – Chemicals & Sustainability https://lnkd.in/evPkPW5K ?? Why Join AgencyIQ? ? Work with top-tier regulatory professionals in life sciences and chemicals ? Shape industry intelligence by analyzing key policy shifts ? Engage with major companies, trade groups, and policymakers ?? Hybrid roles based in Arlington, VA (12 in-office days/month) If you have experience in regulatory affairs—especially with US Environmental Protection Agency (EPA) or FDA—we’d love to hear from you! Apply today or share with someone in your network. #Hiring #RegulatoryAffairs #FoodRegulation #ChemicalsRegulation #Sustainability #EPA #ECHA #FDA #Policy #AgencyIQ #POLITICO
-
?? Trump’s FDA: Two Months In—What’s Changed and What’s Next? ?? The new administration’s deregulatory and downsizing efforts are already reshaping the FDA—and the life sciences industry is feeling the impact. ?? Join AgencyIQ’s expert-led webinar for an insightful breakdown of: ?? Key FDA policy shifts so far—and the impact on drug, biologic, and device regulation ?? What’s next? Early signals on upcoming regulatory changes ?? Staffing shakeups & leadership direction under new FDA Commissioner Marty Makary ?? Emerging trends shaping compliance, approvals, and industry engagement with the agency ?? Get the regulatory intelligence you need to stay ahead—register now! ??https://lnkd.in/e_fKPfn5 #RegulatoryAffairs #FDA #LifeSciences #Pharmaceuticals #MedicalDevices #Biotech #Compliance #AgencyIQ
-
-
?? Is the EU About to Designate ‘Critical Chemicals’? ?? At a Competitiveness Council meeting, France and seven other EU member states pitched the idea of a Critical Chemicals Act—a legislative initiative to secure EU production of 15+ key chemical building blocks, including ethylene, propylene, butadiene, and benzene. ?? What’s at stake? ? Strategic designation for essential chemicals tied to pharmaceuticals, consumer products, and batteries ? Potential funding & trade protections to counter rising energy costs and global competition ? New regulatory focus that could impact supply chains across industries The European Commission will launch a strategic dialogue with industry on March 25, signaling that changes could be coming soon. ?? Get the full breakdown on what’s next for chemical regulations in the US and EU by subscribing to AgencyIQ's free chemicals newsletter, The Periodic. Link in the comments below. #RegulatoryAffairs #ChemicalsRegulation #REACH #EURegulation #ProductStewardship #Sustainability #AgencyIQ
Eight EU member states proposed a strategy this week to boost Europe’s self-sufficiency in chemicals production, calling for legislative incentives to support 15 “strategic” molecules. Their proposal includes ideas like an EU Chips Act-style law, state aid schemes for chemicals projects, and other investment strategies. AgencyIQ has analyzed the key takeaways from this proposal, including the policy suggestions from the proposal and next steps to continue the discussion. I've added our fantastic breakdown from Scott Stephens for my network here on LinkedIn. If you'd like to a look into more of our coverage, send me a message to set up some time for a demo this month! #RegulatoryAffairs #AgencyIQ #EURegulatory #ChemicalsPolicy #CriticalChemicalsAct
-
AgencyIQ is thrilled to welcome David Breyer as our newest Senior Research Analyst and our first team member based in Europe! David brings a deep expertise in EU regulatory policy and a strong background in European institutional decision-making. His experience includes advisory roles at a variety of European institutions and associations, and he was most recently a Policy Advisor at Bundesverband der Pharmazeutischen Industrie (BPI), a German pharmaceutical industry group. With his insights into the evolving EU regulatory landscape, David will play a key role in expanding AgencyIQ’s coverage of regulatory developments in European life sciences and helping our subscribers stay ahead of critical changes. Please join us in welcoming David to the team! ?? #RegulatoryAffairs #EURegulation #LifeSciences #ChemicalsRegulation #PolicyAnalysis #AgencyIQ
-
-
?? The AgencyIQ team just won't rest. From US Environmental Protection Agency (EPA) policy shifts under Trump 2.0 to major EU regulatory updates, our chemicals regulatory intelligence experts have been tracking all the latest changes that impact the chemicals, consumer products, and pesticides industries. ?? Want full access to these expert analyses? Sign up for a free trial of AgencyIQ and stay ahead of the latest regulatory shifts. ?? The sign-up link is in the comments below. #RegulatoryAffairs #ChemicalsRegulation #EPA #TSCA #PFAS #Pesticides #Compliance #Sustainability #AgencyIQ
The past couple of weeks have been busy for AgencyIQ's chemicals research team, and I wanted to share the fantastic coverage we've put up on our platform. Here's a list of some of our top analyses our subscribers have been reading. Feel free to send me a DM on LinkedIn if you'd like a copy of any of these for your own reference! ? What we expect the EPA to do in March 2025 - Julia J., Xiaolu Wang ? What we expect EU regulators to do in March 2025 - Julia J., Scott Stephens ? Chemicals-related EPA updates during the first months of Trump 2.0 - Xiaolu Wang ? Pesticide regulatory digest for the week of Feb. 24, 2025 - Xiaolu Wang, Scott Stephens ? Trump order sets stage for chemicals deregulation via rescinded rules, deprioritized enforcement actions - Xiaolu Wang ? Trump administration actions negatively affecting EPA staff, hiring - Xiaolu Wang ? European Commission amends rules for plastic food contact materials to advance circular economy - Scott Stephens ? France poised to prohibit PFAS in textiles, cosmetics, other consumer products - Scott Stephens
-
?? The AgencyIQ research team has been busy analyzing the latest life sciences regulatory shifts—and this week’s insights are must-reads for policy professionals in the industry. ?? Want to read these full analyses? Sign up for a free trial of AgencyIQ to get access to this week’s insights and so much more. ?? https://lnkd.in/ek-ESmiq #RegulatoryAffairs #FDA #LifeSciences #Compliance #MedicalDevices #Pharma #Biotech #AgencyIQ
Our AgencyIQ research team has been busy this week and I wanted to take a second to highlight some of the amazing analyses our team has published. Below are some of the most read pieces by our subscribers this past week. If you are interested in seeing the full analysis for any of these, please just shoot me a message here on LinkedIn and I would be happy to share! ● Explainer: All the bills in the 119th Congress affecting the FDA - Rachel Coe ● A new executive order cites concerns about industry influence. That could be bad news for FDA’s user fee programs - Alexander Gaffney, MS, RAC ● What We Expect the FDA to do in March and April 2025 ● Device industry lays out robust wish list for new Congress, administration - Laura DiAngelo ● HHS announces it will bypass notice-and-comment process for more regulations ● A guide to staff reductions FDA has already experienced – and those coming soon (updated) ● FDA scrubbed a public meeting on next year's flu vaccine strains. What does that mean for stakeholders? - Amanda Conti ● FDA answers some CGT questions, leaves industry with more ● UPDATED: Commission quietly issues second call for EU reference labs - Corey Jaseph, MS, RAC ● EMA picked up new medicines pace in 2024, but what will 2025 bring? - Sebastian Godoy, MPH ● European trade associations take exception to structured dialogue guidance, propose regulation
-
AgencyIQ转发了
Some insights on recent FDA staff reductions from?POLITICO's?regulatory intelligence experts at?AgencyIQ ??
The government's decision to recently fire hundreds of FDA staff who were in their probationary periods of employment has attracted considerable attention from industry, which has been concerned about the impact of those cuts on review times for new and existing medicines and medical products. But those cuts are just the tip of the iceberg for the FDA. AgencyIQ has been assembling a comprehensive list of the likely cuts that FDA staff will face (or have already begun to face), and have just made that list available on our website for all to read. There are nearly 20 events that will likely reduce FDA's headcount in ways large and small. Make sure you check out our free resource here: https://lnkd.in/e_viaJ-d
-
Join us at AgencyIQ!
Professor/Food & Nutrition Scientist/Regulatory Consulting. Former Dir. FDA CFSAN (Center for Food Safety & Applied Nutrition).
I know that many of you are seeking employment opportunities so sharing an opportunity for a Director of Food and Chemicals Regulatory Research. More specifically, POLITICO is seeking an entrepreneurial thought leader to help lead and expand part of its regulatory policy and intelligence division,?AgencyIQ. See the link below for more information. https://lnkd.in/egtP4hs9